Quantitative determination of clopidogrel active metabolite in human plasma by LC–MS/MS
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 48 (4) , 1219-1224
- https://doi.org/10.1016/j.jpba.2008.08.020
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Determination of clopidogrel in human plasma by liquid chromatography/tandem mass spectrometry: application to a clinical pharmacokinetic studyBiomedical Chromatography, 2007
- The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid raftsProceedings of the National Academy of Sciences, 2006
- Quantification of clopidogrel in human plasma by sensitive liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2006
- Estimation of carboxylic acid metabolite of clopidogrel in Wistar rat plasma by HPLC and its application to a pharmacokinetic studyJournal of Chromatography B, 2005
- Pharmacokinetics of clopidogrel after administration of a high loading doseThrombosis and Haemostasis, 2004
- Structure and Stereochemistry of the Active Metabolite of ClopidogrelDrug Metabolism and Disposition, 2002
- P2Y12, a New Platelet ADP Receptor, Target of ClopidogrelBiochemical and Biophysical Research Communications, 2001
- Identification and Biological Activity of the Active Metabolite of ClopidogrelThrombosis and Haemostasis, 2000
- Assay method for the carboxylic acid metabolite of clopidogrel in human plasma by gas chromatography–mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrelBiochemical Pharmacology, 1992